Opinion|Videos|November 22, 2023
Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist
Author(s)Sara M. Tolaney, MD, MPH
Clinical trials should be considered at any point in a patient's journey with HER2-positive metastatic breast cancer, not just when standard options are exhausted, as they provide early access to promising therapies, novel combinations, and cutting-edge care.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Balance Exercises for Patients With Cancer: How the Single-Leg Stand Builds Stability
2
Wildfire Smoke and Cancer Risk: What Patients Should Know
3
Oncology Nurse Faces Stage 4 Lymphoma Diagnosis — and Returns Stronger
4
Clock Touches: An Advanced Balance Exercise for Patients with Cancer
5